H.U. Group Holdings, Inc.

Tokyo Stock Exchange 4544.T

H.U. Group Holdings, Inc. EBITDA Margin for the year ending March 31, 2024: 5.76%

H.U. Group Holdings, Inc. EBITDA Margin is 5.76% for the year ending March 31, 2024, a -65.11% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

H.U. Group Holdings, Inc. EBITDA Margin for the year ending March 31, 2023 was 16.51%, a -30.80% change year over year.
H.U. Group Holdings, Inc. EBITDA Margin for the year ending March 31, 2022 was 23.86%, a 40.43% change year over year.
H.U. Group Holdings, Inc. EBITDA Margin for the year ending March 31, 2021 was 16.99%, a 50.73% change year over year.
H.U. Group Holdings, Inc. EBITDA Margin for the year ending March 31, 2020 was 11.27%, a -16.04% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Tokyo Stock Exchange: 4544.T

H.U. Group Holdings, Inc.

CEO	Mr. Shigekazu Takeuchi
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	Shinjuku Mitsui Building
Employees	5,295
Sector	Consumers Staples
Industries Cleaning Supplies Biotechnology Dental Care Drugstores & Retail Pharmacies Medical Instruments Personal Care Pharmaceuticals Plastics

Description

H.U. Group Holdings, Inc., through its subsidiaries, provides laboratory testing products and services in Japan. The company offers lab testing and its related services to medical institutions; self-medication services; food, environment, and cosmetic testing services; and testing services through corporate health insurance associations. It also researches, develops, manufactures, and sells in vitro diagnostic devices, which includes the LUMIPULSE, an automatic chemiluminescent enzyme immunoassay system that offers reagents for infectious disease, cancer, and lifestyle disease to medical institutions and testing centers; and ESPRINE, a rapid diagnostics kit series for influenza, hepatitis B, and the novel coronavirus, as well as supplies ingredients for test drugs. In addition, the company provides support services related to hospital administration work, including aid for surgical procedures and endoscope room work, inspection and maintenance services for medical equipment, and in-hospital logistics management and transportation services; and rents and sells nursing-care equipment and supplies. Further, it offers home-visit nursing care services. The company was formerly known as Miraca Holdings Inc. and changed its name to H.U. Group Holdings, Inc. in July 2020. H.U. Group Holdings, Inc. was incorporated in 1950 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years